Identification of Nat-Montelukast:

No description

Search images on Google      Product Monograph

Active Ingredients:

• montelukast (montelukast sodium), 5 MG

DIN: 02522128

Dosage Form(s): TABLET (CHEWABLE)

Route(s) of Administration: ORAL

Schedule: Prescription

Company: NATCO PHARMA (CANADA) INC

ATC:

• R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO, Wiki)
• R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO)
• R03DC - Leukotriene receptor antagonists (ATC, WHO)
• R03DC03 - MONTELUKAST (WHO)

Reference brand drug: Singulair

Pharmaceutical standard: MFR

 

External Links for Nat-Montelukast:

Search on Google

• Nat-Montelukast side effects
• Nat-Montelukast dosage
• montelukast side effects
• montelukast dosage